{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T18:33:12Z","timestamp":1771007592174,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2016,8,9]],"date-time":"2016-08-09T00:00:00Z","timestamp":1470700800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"hospital general universitario alicante","award":["UGP-14-270"],"award-info":[{"award-number":["UGP-14-270"]}]},{"name":"Fundaci\u00f3n Soria Melguizo","award":["2015"],"award-info":[{"award-number":["2015"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1007\/s10096-016-2737-2","type":"journal-article","created":{"date-parts":[[2016,8,9]],"date-time":"2016-08-09T04:46:28Z","timestamp":1470717988000},"page":"1851-1855","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Empirical monotherapy with meropenem or combination therapy: the microbiological point of view"],"prefix":"10.1007","volume":"35","author":[{"given":"P.","family":"Garcinu\u00f1o","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Santiba\u00f1ez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Gimeno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"S\u00e1nchez-Bautista","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Coy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"S\u00e1nchez-Paya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Boix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Merino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Portilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. C.","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,8,9]]},"reference":[{"key":"2737_CR1","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1097\/01.CCM.0000217961.75225.E9","volume":"34","author":"A Kumar","year":"2006","unstructured":"Kumar A, Roberts D, Wood KE et al (2006) Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34:1589\u20131596","journal-title":"Crit Care Med"},{"key":"2737_CR2","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1099\/jmm.0.073262-0","volume":"63","author":"RC Dantas","year":"2014","unstructured":"Dantas RC, Ferreira ML, Gontijo-Filho PP et al (2014) Pseudomonas aeruginosa bacteraemia: independent risk factors for mortality and impact of resistance on outcome. J Med Microbiol 63:1679\u20131687","journal-title":"J Med Microbiol"},{"key":"2737_CR3","first-page":"193","volume":"20","author":"I Mu\u00f1oz","year":"2007","unstructured":"Mu\u00f1oz I, Vanaclocha H, Gonz\u00e1lez F (2007) The importance of microbiological surveillance networks in monitoring resistant bacteria. RedMIVA. Rev Esp Quimioter 20:193\u2013202","journal-title":"Rev Esp Quimioter"},{"key":"2737_CR4","unstructured":"European Centre for Disease Prevention and Control. EARSS Annual Report of antimicrobial resistance surveillance in Europe. http:\/\/ecdc.europa.eu\/en\/publications\/surveillance_reports"},{"issue":"Suppl 4","key":"2737_CR5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0213-005X(13)70129-0","volume":"31","author":"P Retamar","year":"2013","unstructured":"Retamar P, Luisa Mart\u00edn M, Molina J et al (2013) Evaluating the quality of antimicrobial prescribing: is standardisation possible? Enferm Infecc Microbiol Clin 31 [Suppl 4]:25\u201330","journal-title":"Enferm Infecc Microbiol Clin"},{"issue":"Suppl 4","key":"2737_CR6","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0213-005X(13)70127-7","volume":"31","author":"E Calbo","year":"2013","unstructured":"Calbo E, Alvarez-Rocha L, Gudiol F et al (2013) A review of the factors influencing antimicrobial prescribing. Enferm Infecc Microbiol Clin 31 [Suppl 4]:12\u201315","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"2737_CR7","volume":"9","author":"PK Yokota","year":"2014","unstructured":"Yokota PK, Marra AR, Martino MD et al (2014) Impact of appropriate antimicrobial therapy for patients with severe sepsis and septic shock\u2014a quality improvement study. PLoS One 9, e104475","journal-title":"PLoS One"},{"key":"2737_CR8","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1177\/1060028015578259","volume":"49","author":"BA Faine","year":"2015","unstructured":"Faine BA, Harland KK, Porter B et al (2015) A clinical decision rule identifies risk factors associated with antimicrobial-resistant urinary pathogens in the emergency department: a retrospective validation study. Ann Pharmacother 49:649\u2013655","journal-title":"Ann Pharmacother"},{"key":"2737_CR9","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1097\/INF.0000000000000652","volume":"34","author":"JA Bielicki","year":"2015","unstructured":"Bielicki JA, Lundin R, Sharland M, ARPEC Project (2015) Antibiotic resistance prevalence in routine bloodstream isolates from children\u2019s hospitals varies substantially from adult surveillance data in Europe. Pediatr Infect Dis J 34:734\u2013741","journal-title":"Pediatr Infect Dis J"},{"key":"2737_CR10","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/joim.12342","volume":"277","author":"T T\u00e4ngd\u00e9n","year":"2015","unstructured":"T\u00e4ngd\u00e9n T, Giske CG (2015) Global dissemination of extensively drug-resistant carbapenemase-producing Enterobacteriaceae: clinical perspectives on detection, treatment and infection control. J Intern Med 277:501\u2013512","journal-title":"J Intern Med"},{"key":"2737_CR11","doi-asserted-by":"crossref","first-page":"E3574","DOI":"10.1073\/pnas.1501049112","volume":"112","author":"KE Holt","year":"2015","unstructured":"Holt KE, Wertheim H, Zadoks RN et al (2015) Genomic analysis of diversity, population structure, virulence, and antimicrobial resistance in Klebsiella pneumoniae, an urgent threat to public health. Proc Natl Acad Sci U S A 112:E3574\u2013E3581","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2737_CR12","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1093\/jac\/dkv200","volume":"70","author":"M Tumbarello","year":"2015","unstructured":"Tumbarello M, Trecarichi EM, De Rosa FG et al (2015) Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study. J Antimicrob Chemother 70:2133\u20132143","journal-title":"J Antimicrob Chemother"},{"key":"2737_CR13","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/s00134-015-3719-z","volume":"41","author":"M Bassetti","year":"2015","unstructured":"Bassetti M, De Waele JJ, Eggimann P et al (2015) Preventive and therapeutic strategies in critically ill patients with highly resistant bacteria. Intensive Care Med 41:776\u2013795","journal-title":"Intensive Care Med"},{"key":"2737_CR14","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.cmi.2015.05.013","volume":"21","author":"MM Brigmon","year":"2015","unstructured":"Brigmon MM, Bookstaver PB, Kohn J et al (2015) Impact of fluoroquinolone resistance in Gram-negative bloodstream infections on healthcare utilization. Rapid nucleic acid diagnostics for the detection of antimicrobial resistance in Gram-negative bacteria: is it time for a paradigm shift? Clin Microbiol Infect 21:843\u2013849","journal-title":"Clin Microbiol Infect"},{"key":"2737_CR15","doi-asserted-by":"crossref","first-page":"6344","DOI":"10.1128\/AAC.01513-13","volume":"57","author":"J Oteo","year":"2013","unstructured":"Oteo J, Saez D, Bautista V, Fern\u00e1ndez-Romero S, Hern\u00e1ndez-Molina JM, P\u00e9rez-V\u00e1zquez M, Aracil B, Campos J, Spanish Collaborating Group for the Antibiotic Resistance Surveillance Program (2013) Carbapenemase-producing enterobacteriaceae in Spain in 2012. Antimicrob Agents Chemother 57:6344\u20136347","journal-title":"Antimicrob Agents Chemother"},{"key":"2737_CR16","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1093\/cid\/cit070","volume":"56","author":"JG Bartlett","year":"2013","unstructured":"Bartlett JG, Gilbert DN, Spellberg B (2013) Seven ways to preserve the miracle of antibiotics. Clin Infect Dis 56:1445\u20131450","journal-title":"Clin Infect Dis"},{"key":"2737_CR17","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1093\/jac\/dku083","volume":"69","author":"N Tuite","year":"2014","unstructured":"Tuite N, Reddington K, Barry T, Zumla A, Enne V (2014) Rapid nucleic acid diagnostics for the detection of antimicrobial resistance in Gram-negative bacteria: is it time for a paradigm shift? J Antimicrob Chemother 69:1729\u20131733","journal-title":"J Antimicrob Chemother"},{"key":"2737_CR18","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1001\/jama.2013.283828","volume":"310","author":"BM Kuehn","year":"2013","unstructured":"Kuehn BM (2013) IDSA: better, faster diagnostics for infectious diseases needed to curb overtreatment, antibiotic resistance. JAMA 310:2385\u20132386","journal-title":"JAMA"},{"key":"2737_CR19","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1093\/cid\/cit571","volume":"57","author":"T Maruyama","year":"2013","unstructured":"Maruyama T, Fujisawa T, Okuno M, Toyoshima H, Tsutsui K, Maeda H, Yuda H, Yoshida M, Kobayashi H, Taguchi O, Gabazza EC, Takei Y, Miyashita N, Ihara T, Brito V, Niederman MS (2013) A new strategy for healthcare-associated pneumonia: a 2-year prospective multicenter cohort study using risk factors for multidrug-resistant pathogens to select initial empiric therapy. Clin Infect Dis 57:1373\u20131383","journal-title":"Clin Infect Dis"},{"key":"2737_CR20","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.1128\/AAC.00091-15","volume":"59","author":"SN Bass","year":"2015","unstructured":"Bass SN, Bauer SR, Neuner EA, Lam SW (2015) Impact of combination antimicrobial therapy on mortality risk for critically ill patients with carbapenem-resistant bacteremia. Antimicrob Agents Chemother 59:3748\u20133753","journal-title":"Antimicrob Agents Chemother"},{"key":"2737_CR21","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1586\/14787210.2013.846215","volume":"11","author":"JG Kmeid","year":"2013","unstructured":"Kmeid JG, Youssef MM, Kanafani ZA, Kanj SS (2013) Combination therapy for Gram-negative bacteria: what is the evidence? Expert Rev Anti Infect Ther 11:1355\u20131362","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2737_CR22","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1128\/AAC.01222-13","volume":"58","author":"ME Falagas","year":"2014","unstructured":"Falagas ME, Lourida P, Poulikakos P, Rafailidis PI, Tansarli GS (2014) Antibiotic treatment of infections due to carbapenem-resistant Enterobacteriaceae: systematic evaluation of the available evidence. Antimicrob Agents Chemother 58:654\u2013663","journal-title":"Antimicrob Agents Chemother"},{"key":"2737_CR23","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.coph.2015.07.001","volume":"24","author":"P Viale","year":"2015","unstructured":"Viale P, Giannella M, Tedeschi S, Lewis R (2015) Treatment of MDR-Gram negative infections in the 21st century: a never ending threat for clinicians. Curr Opin Pharmacol 24:30\u201337","journal-title":"Curr Opin Pharmacol"},{"key":"2737_CR24","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1017\/ice.2015.196","volume":"36","author":"AJ Hsu","year":"2015","unstructured":"Hsu AJ, Carroll KC, Milstone AM, Avdic E, Cosgrove SE, Vilasoa M, Tamma PD (2015) The use of a combination antibiogram to assist with the selection of appropriate antimicrobial therapy for carbapenemase-producing enterobacteriaceae infections. Infect Control Hosp Epidemiol 36:1458\u20131460","journal-title":"Infect Control Hosp Epidemiol"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-016-2737-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-016-2737-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-016-2737-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T20:14:39Z","timestamp":1498335279000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-016-2737-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,9]]},"references-count":24,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["2737"],"URL":"https:\/\/doi.org\/10.1007\/s10096-016-2737-2","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,9]]}}}